Rationale, timeline, study design, and protocol overview of the therapeutic hypothermia after pediatric cardiac arrest trials

Frank W. Moler, Faye S. Silverstein, Kathleen L. Meert, Amy E. Clark, Richard Holubkov, Brittan Browning, Beth S Slomine, James R Christensen, J. Michael Dean

Research output: Contribution to journalArticle

Abstract

Objective: To describe the rationale, timeline, study design, and protocol overview of the Therapeutic Hypothermia after Pediatric Cardiac Arrest trials. Design: Multicenter randomized controlled trials. Setting: Pediatric intensive care and cardiac ICUs in the United States and Canada. Patients: Children from 48 hours to 18 years old, who have return of circulation after cardiac arrest, who meet trial eligibility criteria, and whose guardians provide written consent. Interventions: Therapeutic hypothermia or therapeutic normothermia. Measurements and Main Results: From concept inception in 2002 until trial initiation in 2009, 7 years were required to plan and operationalize the Therapeutic Hypothermia after Pediatric Cardiac Arrest trials. Two National Institute of Child Health and Human Development clinical trial planning grants (R21 and R34) supported feasibility assessment and protocol development. Two clinical research networks, Pediatric Emergency Care Applied Research Network and Collaborative Pediatric Critical Care Research Network, provided infrastructure resources. Two National Heart Lung Blood Institute U01 awards provided funding to conduct separate trials of in-hospital and out-of-hospital cardiac arrest. A pilot vanguard phase that included half the clinical sites began on March 9, 2009, and this was followed by full trial funding through 2015. Conclusions: Over a decade will have been required to plan, design, operationalize, and conduct the Therapeutic Hypothermia after Pediatric Cardiac Arrest trials. Details described in this report, such as participation of clinical research networks and clinical trial planning grants utilization, may be of utility for individuals who are planning investigator-initiated, federally supported clinical trials.

Original languageEnglish (US)
Pages (from-to)e304-e315
JournalPediatric Critical Care Medicine
Volume14
Issue number7
DOIs
StatePublished - 2013

Fingerprint

Induced Hypothermia
Heart Arrest
Pediatrics
Organized Financing
Clinical Trials
Critical Care
Research
National Institute of Child Health and Human Development (U.S.)
National Heart, Lung, and Blood Institute (U.S.)
Out-of-Hospital Cardiac Arrest
Emergency Medical Services
Canada
TimeLine
Randomized Controlled Trials
Research Personnel

Keywords

  • Cardiac arrest
  • In hospital
  • Mortality
  • Multicenter
  • Out of hospital
  • Outcome
  • Pediatric
  • Randomized controlled trial
  • Targeted temperature control
  • Therapeutic hypothermia
  • Therapeutic normothermia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Critical Care and Intensive Care Medicine

Cite this

Moler, F. W., Silverstein, F. S., Meert, K. L., Clark, A. E., Holubkov, R., Browning, B., ... Dean, J. M. (2013). Rationale, timeline, study design, and protocol overview of the therapeutic hypothermia after pediatric cardiac arrest trials. Pediatric Critical Care Medicine, 14(7), e304-e315. https://doi.org/10.1097/PCC.0b013e31828a863a

Rationale, timeline, study design, and protocol overview of the therapeutic hypothermia after pediatric cardiac arrest trials. / Moler, Frank W.; Silverstein, Faye S.; Meert, Kathleen L.; Clark, Amy E.; Holubkov, Richard; Browning, Brittan; Slomine, Beth S; Christensen, James R; Dean, J. Michael.

In: Pediatric Critical Care Medicine, Vol. 14, No. 7, 2013, p. e304-e315.

Research output: Contribution to journalArticle

Moler, Frank W. ; Silverstein, Faye S. ; Meert, Kathleen L. ; Clark, Amy E. ; Holubkov, Richard ; Browning, Brittan ; Slomine, Beth S ; Christensen, James R ; Dean, J. Michael. / Rationale, timeline, study design, and protocol overview of the therapeutic hypothermia after pediatric cardiac arrest trials. In: Pediatric Critical Care Medicine. 2013 ; Vol. 14, No. 7. pp. e304-e315.
@article{effb572235c249a2b1e9d0e1ea4fe1a8,
title = "Rationale, timeline, study design, and protocol overview of the therapeutic hypothermia after pediatric cardiac arrest trials",
abstract = "Objective: To describe the rationale, timeline, study design, and protocol overview of the Therapeutic Hypothermia after Pediatric Cardiac Arrest trials. Design: Multicenter randomized controlled trials. Setting: Pediatric intensive care and cardiac ICUs in the United States and Canada. Patients: Children from 48 hours to 18 years old, who have return of circulation after cardiac arrest, who meet trial eligibility criteria, and whose guardians provide written consent. Interventions: Therapeutic hypothermia or therapeutic normothermia. Measurements and Main Results: From concept inception in 2002 until trial initiation in 2009, 7 years were required to plan and operationalize the Therapeutic Hypothermia after Pediatric Cardiac Arrest trials. Two National Institute of Child Health and Human Development clinical trial planning grants (R21 and R34) supported feasibility assessment and protocol development. Two clinical research networks, Pediatric Emergency Care Applied Research Network and Collaborative Pediatric Critical Care Research Network, provided infrastructure resources. Two National Heart Lung Blood Institute U01 awards provided funding to conduct separate trials of in-hospital and out-of-hospital cardiac arrest. A pilot vanguard phase that included half the clinical sites began on March 9, 2009, and this was followed by full trial funding through 2015. Conclusions: Over a decade will have been required to plan, design, operationalize, and conduct the Therapeutic Hypothermia after Pediatric Cardiac Arrest trials. Details described in this report, such as participation of clinical research networks and clinical trial planning grants utilization, may be of utility for individuals who are planning investigator-initiated, federally supported clinical trials.",
keywords = "Cardiac arrest, In hospital, Mortality, Multicenter, Out of hospital, Outcome, Pediatric, Randomized controlled trial, Targeted temperature control, Therapeutic hypothermia, Therapeutic normothermia",
author = "Moler, {Frank W.} and Silverstein, {Faye S.} and Meert, {Kathleen L.} and Clark, {Amy E.} and Richard Holubkov and Brittan Browning and Slomine, {Beth S} and Christensen, {James R} and Dean, {J. Michael}",
year = "2013",
doi = "10.1097/PCC.0b013e31828a863a",
language = "English (US)",
volume = "14",
pages = "e304--e315",
journal = "Pediatric Critical Care Medicine",
issn = "1529-7535",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

TY - JOUR

T1 - Rationale, timeline, study design, and protocol overview of the therapeutic hypothermia after pediatric cardiac arrest trials

AU - Moler, Frank W.

AU - Silverstein, Faye S.

AU - Meert, Kathleen L.

AU - Clark, Amy E.

AU - Holubkov, Richard

AU - Browning, Brittan

AU - Slomine, Beth S

AU - Christensen, James R

AU - Dean, J. Michael

PY - 2013

Y1 - 2013

N2 - Objective: To describe the rationale, timeline, study design, and protocol overview of the Therapeutic Hypothermia after Pediatric Cardiac Arrest trials. Design: Multicenter randomized controlled trials. Setting: Pediatric intensive care and cardiac ICUs in the United States and Canada. Patients: Children from 48 hours to 18 years old, who have return of circulation after cardiac arrest, who meet trial eligibility criteria, and whose guardians provide written consent. Interventions: Therapeutic hypothermia or therapeutic normothermia. Measurements and Main Results: From concept inception in 2002 until trial initiation in 2009, 7 years were required to plan and operationalize the Therapeutic Hypothermia after Pediatric Cardiac Arrest trials. Two National Institute of Child Health and Human Development clinical trial planning grants (R21 and R34) supported feasibility assessment and protocol development. Two clinical research networks, Pediatric Emergency Care Applied Research Network and Collaborative Pediatric Critical Care Research Network, provided infrastructure resources. Two National Heart Lung Blood Institute U01 awards provided funding to conduct separate trials of in-hospital and out-of-hospital cardiac arrest. A pilot vanguard phase that included half the clinical sites began on March 9, 2009, and this was followed by full trial funding through 2015. Conclusions: Over a decade will have been required to plan, design, operationalize, and conduct the Therapeutic Hypothermia after Pediatric Cardiac Arrest trials. Details described in this report, such as participation of clinical research networks and clinical trial planning grants utilization, may be of utility for individuals who are planning investigator-initiated, federally supported clinical trials.

AB - Objective: To describe the rationale, timeline, study design, and protocol overview of the Therapeutic Hypothermia after Pediatric Cardiac Arrest trials. Design: Multicenter randomized controlled trials. Setting: Pediatric intensive care and cardiac ICUs in the United States and Canada. Patients: Children from 48 hours to 18 years old, who have return of circulation after cardiac arrest, who meet trial eligibility criteria, and whose guardians provide written consent. Interventions: Therapeutic hypothermia or therapeutic normothermia. Measurements and Main Results: From concept inception in 2002 until trial initiation in 2009, 7 years were required to plan and operationalize the Therapeutic Hypothermia after Pediatric Cardiac Arrest trials. Two National Institute of Child Health and Human Development clinical trial planning grants (R21 and R34) supported feasibility assessment and protocol development. Two clinical research networks, Pediatric Emergency Care Applied Research Network and Collaborative Pediatric Critical Care Research Network, provided infrastructure resources. Two National Heart Lung Blood Institute U01 awards provided funding to conduct separate trials of in-hospital and out-of-hospital cardiac arrest. A pilot vanguard phase that included half the clinical sites began on March 9, 2009, and this was followed by full trial funding through 2015. Conclusions: Over a decade will have been required to plan, design, operationalize, and conduct the Therapeutic Hypothermia after Pediatric Cardiac Arrest trials. Details described in this report, such as participation of clinical research networks and clinical trial planning grants utilization, may be of utility for individuals who are planning investigator-initiated, federally supported clinical trials.

KW - Cardiac arrest

KW - In hospital

KW - Mortality

KW - Multicenter

KW - Out of hospital

KW - Outcome

KW - Pediatric

KW - Randomized controlled trial

KW - Targeted temperature control

KW - Therapeutic hypothermia

KW - Therapeutic normothermia

UR - http://www.scopus.com/inward/record.url?scp=84903678095&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903678095&partnerID=8YFLogxK

U2 - 10.1097/PCC.0b013e31828a863a

DO - 10.1097/PCC.0b013e31828a863a

M3 - Article

C2 - 23842585

AN - SCOPUS:84903678095

VL - 14

SP - e304-e315

JO - Pediatric Critical Care Medicine

JF - Pediatric Critical Care Medicine

SN - 1529-7535

IS - 7

ER -